Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 13, 2021

SELL
$8.2 - $12.4 $1.81 Million - $2.73 Million
-220,321 Closed
0 $0
Q4 2020

Jan 19, 2021

BUY
$11.2 - $27.7 $190,400 - $470,900
17,000 Added 8.36%
220,321 $458,000
Q3 2020

Oct 09, 2020

BUY
$10.6 - $16.6 $795,000 - $1.25 Million
75,000 Added 58.45%
203,321 $252,000
Q2 2020

Jul 10, 2020

BUY
$10.3 - $17.3 $604,826 - $1.02 Million
58,721 Added 84.37%
128,321 $164,000
Q1 2020

Apr 09, 2020

BUY
$11.0 - $31.7 $765,600 - $2.21 Million
69,600 New
69,600 $88,000

About Cellectar Biosciences, Inc.


  • Ticker CLRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 6,114,290
  • Market Cap $1.47M
  • Description
  • Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's ma...
More about CLRB
Track This Portfolio

Track Fny Investment Advisers, LLC Portfolio

Follow Fny Investment Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fny Investment Advisers, LLC with notifications on news.